Stock comparison
LeMaitre Vascular
The Pennant Group
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.32B
Sector
Healthcare
PNTG
The Pennant Group
Market cap
$1.19B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | PNTG | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 59C | LMAT |
| Benjamin Graham | 81A | 76B | LMAT |
| Philip Fisher | 73B | 59C | LMAT |
| Peter Lynch | 59C | 50C | LMAT |
| Joel Greenblatt | 48D | 43D | LMAT |
| Charlie Munger | 60C | 38D | LMAT |
| Terry Smith | 61C | 35D | LMAT |
Side-by-side metrics
| Metric | LMAT | PNTG |
|---|---|---|
| Market cap | $2.32B | $1.19B |
| P/E (TTM) | 37.1x | 39.1x |
| EV/EBIT | 36.6x | 31.7x |
| ROIC (TTM) | 9.43% | 4.96% |
| Gross margin | 72.39% | 14.78% |
| Net margin | 24.35% | 2.96% |
| Revenue CAGR 5y | 12.75% | 21.17% |
| EPS CAGR 5y | 19.04% | 83.65% |
| Debt / Equity | 0.5x | 1.3x |
| Dividend yield | 0.84% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- Dividend yield0.84%vs 0.0%+100%
- Net margin24.35%vs 2.96%+88%
- Gross margin72.39%vs 14.78%+80%
- Debt / Equity0.5xvs 1.3x+64%
PNTG leads on
- EPS CAGR 5y83.65%vs 19.04%+77%
- Revenue CAGR 5y21.17%vs 12.75%+40%
- EV/EBIT31.7xvs 36.6x+13%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.